HuGE Literature Finder
Records
1
-
15
| Infrequent RAS mutation is not associated with specific histological phenotype in gliomas. BMC cancer 2021 Sep 21 (1): 1025. Makino Yasuhide, Arakawa Yoshiki, Yoshioka Ema, Shofuda Tomoko, Minamiguchi Sachiko, Kawauchi Takeshi, Tanji Masahiro, Kanematsu Daisuke, Nonaka Masahiro, Okita Yoshiko, Kodama Yoshinori, Mano Masayuki, Hirose Takanori, Mineharu Yohei, Miyamoto Susumu, Kanemura Yonehi |
| BRAF more frequently co-occurs with IDH1/2 mutations in adult patients with gliomas than in patients harboring BRAF but without a survival advantage. BMC neurology 2021 May 21 (1): 195. Wang Wei, Wang Maode, Jiang Haitao, Wang Tuo, Da Ro |
| Genetic signature and treatment of pediatric high-grade glioma. Molecular and clinical oncology 2021 Apr 14 (4): 70. Guidi Milena, Giunti Laura, Buccoliero Anna Maria, Caporalini Chiara, Censullo Maria Luigia, Galli Luisa, Genitori Lorenzo, Sardi Iaco |
| Pan-Cancer Efficacy of Vemurafenib in BRAF-Mutant Non-Melanoma Cancers. Cancer discovery 2020 Feb . Subbiah Vivek, Puzanov Igor, Blay Jean-Yves, Chau Ian, Lockhart Albert Craig, Raje Noopur S, Wolf Juergen, Baselga Jose, Meric-Bernstam Funda, Roszik Jason, Diamond Eli L, Riely Gregory J, Sherman Eric J, Riehl Todd, Pitcher Bethany, Hyman David |
| Genomic Profiling Identified Novel Prognostic Biomarkers in Chinese Midline Glioma Patients. Frontiers in oncology 2020 10 607429. Li Hainan, Shan Changguo, Wu Shengnan, Cheng Baijie, Fan Chongzu, Cai Linbo, Chen Yedan, Shi Yuqian, Liu Kaihua, Shao Yang, Zhu Dan, Li Z |
| Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
| Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing. Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
| Racial Disparities in the Molecular Landscape of Cancer. Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
| Diagnostic yield of targeted next generation sequencing in various cancer types: an information-theoretic approach. Cancer genetics 2015 Sep 208 (9): 441-7. Hagemann Ian S, O'Neill Patrick K, Erill Ivan, Pfeifer John |
| Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
| BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Mar 33 (9): 1015-22. Mistry Matthew, Zhukova Nataliya, Merico Daniele, Rakopoulos Patricia, Krishnatry Rahul, Shago Mary, Stavropoulos James, Alon Noa, Pole Jason D, Ray Peter N, Navickiene Vilma, Mangerel Joshua, Remke Marc, Buczkowicz Pawel, Ramaswamy Vijay, Guerreiro Stucklin Ana, Li Martin, Young Edwin J, Zhang Cindy, Castelo-Branco Pedro, Bakry Doua, Laughlin Suzanne, Shlien Adam, Chan Jennifer, Ligon Keith L, Rutka James T, Dirks Peter B, Taylor Michael D, Greenberg Mark, Malkin David, Huang Annie, Bouffet Eric, Hawkins Cynthia E, Tabori U |
| Isocitrate dehydrogenase 1 R132C mutation occurs exclusively in microsatellite stable colorectal cancers with the CpG island methylator phenotype. Epigenetics 2014 Nov 9 (11): 1454-60. Whitehall V L J, Dumenil T D, McKeone D M, Bond C E, Bettington M L, Buttenshaw R L, Bowdler L, Montgomery G W, Wockner L F, Leggett B |
| TERT promoter mutations and BRAF mutations are rare in sporadic, and TERT promoter mutations are absent in NF1-related malignant peripheral nerve sheath tumors. Journal of neuro-oncology 2014 Nov 120 (2): 267-72. Dubbink Hendrikus J, Bakels Hannah, Post Edward, Zwarthoff Ellen C, Verdijk Robert |
| BRAF, GNAQ, and GNA11 mutations and copy number in pediatric low-grade glioma. FEBS open bio 2012 2 129-34. Laviv Yosef, Toledano Helen, Michowiz Shalom, Dratviman-Storobinsky Olga, Turm Yuval, Fichman-Horn Suzana, Kagnovski Ella, Goldenberg-Cohen Nit |
| Investigation of gene dosage imbalances in patients with Noonan syndrome using multiplex ligation-dependent probe amplification analysis. European journal of medical genetics 0 53 (3): 117-21. Nyström Anna-Maja, Ekvall Sara, Thuresson Ann-Charlotte, Denayer Ellen, Legius Eric, Kamali-Moghaddam Masood, Westermark Bengt, Annerén Göran, Bondeson Marie-Loui |
- Page last reviewed:Jul 25, 2022
- Page last updated:Aug 10, 2022
- Content source: